← back to search

Kenneth Meredith

Florida State University · US
Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Esophageal Cancer Research and Treatment, Gastric Cancer Management and Outcomes, Pancreatic and Hepatic Oncology Research, and Esophageal and GI Pathology.
h-index
30
citations
4,215
works
216
NIH funding
primary concept
email

Recent publications

Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-naïve patients with pancreatic ductal adenocarcinoma
Frontiers in Oncology 2024cited by 12position: middledoi
Esophageal cancer in Hispanics: a demographic analysis of the National Cancer Database
Journal of Gastrointestinal Surgery 2024cited by 2position: lastdoi
The effects of the tumor suppressor gene PTEN on the proliferation and apoptosis of breast cancer cells via AKT phosphorylation
Translational Cancer Research 2023cited by 14position: middledoi
The use of indocyanine green (ICYG) angiography intraoperatively to evaluate gastric conduit perfusion during esophagectomy: does it impact surgical decision-making?
Surgical Endoscopy 2023cited by 12position: lastdoi
Timing After Neoadjuvant Therapy Predicts Mortality in Patients Undergoing Esophagectomy: a Propensity Score–Matched Analysis
Journal of Gastrointestinal Surgery 2023cited by 5position: lastdoi
Efficacy and safety of esophagectomy via left thoracic approach versus via right thoracic approach for middle and lower thoracic esophageal cancer: a multicenter randomized clinical trial (NST1501)
Annals of Translational Medicine 2022cited by 8position: middledoi
Adjuvant therapy for margin positive pancreatic cancer: A propensity score matched analysis
Pancreatology 2022cited by 5position: lastdoi
Correlation Between Lymph Node Resection and Survival in Patients with Pancreatic Cancer
Journal of the American College of Surgeons 2022cited by 1position: lastdoi
Evaluation of the Relationship between Lymph Node Harvest and Survival in Pancreatic Cancer
HPB 2022cited by 1position: lastdoi
Comparative outcomes of minimally invasive and open gastrectomy.
Journal of Clinical Oncology 2022cited by 0position: lastdoi
Correlation of surgical volume and outcomes with gastrectomy.
Journal of Clinical Oncology 2022cited by 0position: lastdoi
Comparative outcomes of transthoracic versus transhiatal esophagectomy
Surgery 2021cited by 19position: lastdoi
The Florida Pancreas Collaborative Next-Generation Biobank: Infrastructure to Reduce Disparities and Improve Survival for a Diverse Cohort of Patients with Pancreatic Cancer
Cancers 2021cited by 18position: middledoi
Sepsis and pancreatic cancer: Biliary stents a significant risk factor in patients undergoing chemotherapy.
Journal of Clinical Oncology 2021cited by 3position: middledoi
Resection rate of locally advanced pancreatic cancer in gemcitabine plus nab-paclitaxel versus FOLFIRINOX.
Journal of Clinical Oncology 2021cited by 0position: middledoi
Evaluation of the current treatment strategies for pancreatic neuroendocrine tumors: a propensity score matched analysis
HPB 2021cited by 0position: firstdoi
Prognostic significance of CA 19-9
HPB 2021cited by 0position: firstdoi
Demographic differences of colorectal cancer in the community and academic setting in patients over the age of 75 compared to those aged 50 to 75.
Journal of Clinical Oncology 2021cited by 0position: lastdoi
Comparison of colorectal cancer location and metastasis site in patients aged 50 to 75 versus age 75 and older in community and academic practice.
Journal of Clinical Oncology 2021cited by 0position: lastdoi
High-Volume Surgeons Have Improved Outcomes after Robotic Transthoracic Esophagectomy in the Community Setting
Journal of the American College of Surgeons 2021cited by 0position: middledoi
S447 Anastomotic Leaks Post Esophagectomy: Do Comorbidities Matter?
The American Journal of Gastroenterology 2021cited by 0position: lastdoi
Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study
The Lancet Child & Adolescent Health 2020cited by 416position: middledoi
Multi-agent neoadjuvant chemotherapy improves response and survival in patients with resectable pancreatic cancer
Journal of Gastrointestinal Oncology 2020cited by 5position: lastdoi
Age-related outcomes in patients with esophageal cancer: A propensity score matched analysis.
Journal of Clinical Oncology 2020cited by 0position: lastdoi
Evaluation of the current treatment strategies for pancreatic neuroendocrine tumors.
Journal of Clinical Oncology 2020cited by 0position: firstdoi
The Florida Pancreas Collaborative Next-Generation Biobank: State-wide Infrastructure to Reduce Disparities and Improve Survival for a Racially and Ethnically Diverse Cohort of Patients with Pancreatic Cancer
medRxiv 2020cited by 0position: middledoi
Comparative Perioperative Outcomes by Esophagectomy Surgical Technique
Journal of Gastrointestinal Surgery 2019cited by 31position: firstdoi
Comparative outcomes of minimally invasive and robotic-assisted esophagectomy
Surgical Endoscopy 2019cited by 30position: firstdoi
Timing after neoadjuvant therapy predicts mortality in patients undergoing esophagectomy.
Journal of Clinical Oncology 2019cited by 1position: lastdoi
Esophageal cancer in Hispanic patients: A demographic analysis of the National Cancer Database.
Journal of Clinical Oncology 2019cited by 1position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Ravi Shridhar · University of South Florida44 papers (2016–2024)Jamie Huston · Florida State University36 papers (2017–2024)Caitlin Takahashi · Florida State University9 papers (2018–2023)Sarah E. Hoffe · University of South Florida9 papers (2016–2017)Taylor Maramara · Florida State University9 papers (2019–2023)Paige Blinn · University of Illinois Chicago7 papers (2019–2023)Khaldoun Almhanna · Brown University7 papers (2016–2017)Jessica M. Frakes · University of South Florida5 papers (2016–2017)Jamie Glasser · Florida State University4 papers (2021–2022)Eric A. Mellon · Henry Ford Health System4 papers (2016–2017)R. H. Brown · PsiOxus Therapeutics (United Kingdom)3 papers (2016–2017)C. Schuster · Florida State University3 papers (2021–2022)Gregory M. Springett · Sylvester Comprehensive Cancer Center3 papers (2016–2017)Ian Nora · Florida State University3 papers (2017–2021)P. Briceno · Florida State University3 papers (2017–2018)José M. Pimiento · University of South Florida2 papers (2017–2017) · 2 papers (2017–2017)Charles D. Lopez · University of Nariño2 papers (2021–2021)Jason Klapman · Moffitt Cancer Center2 papers (2016–2016) · 2 papers (2021–2021)